• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Alcoholic liver disease.酒精性肝病
Postgrad Med J. 2000 May;76(895):280-6. doi: 10.1136/pmj.76.895.280.
2
Therapy for alcoholic liver disease.酒精性肝病的治疗
World J Gastroenterol. 2014 Mar 7;20(9):2143-58. doi: 10.3748/wjg.v20.i9.2143.
3
[New suggestions for the management of alcoholic liver diseases].[酒精性肝病管理的新建议]
Acta Gastroenterol Latinoam. 1995;25(2):73-84.
4
Alcohol and the liver.酒精与肝脏
Curr Opin Gastroenterol. 2006 May;22(3):263-71. doi: 10.1097/01.mog.0000218963.93806.d3.
5
[Alcoholic liver disease].[酒精性肝病]
Wiad Lek. 2003;56(1-2):61-70.
6
Diagnosis and management of alcoholic liver disease.酒精性肝病的诊断与治疗。
J Dig Dis. 2011 Aug;12(4):257-62. doi: 10.1111/j.1751-2980.2010.00470.x.
7
Alcoholic liver disease. Treatment strategies for the potentially reversible stages.酒精性肝病。潜在可逆阶段的治疗策略。
Postgrad Med. 1998 Apr;103(4):261-4, 267-8, 273-5. doi: 10.3810/pgm.1998.04.462.
8
Liver damage: mechanisms and management.肝损伤:机制与管理
Br Med Bull. 1994 Jan;50(1):124-38. doi: 10.1093/oxfordjournals.bmb.a072871.
9
Review article: current management of alcoholic liver disease.综述文章:酒精性肝病的当前管理
Aliment Pharmacol Ther. 2004 Apr 1;19(7):707-14. doi: 10.1111/j.1365-2036.2004.01881.x.
10
Pathogenesis of Alcoholic Liver Disease.酒精性肝病的发病机制
Clin Liver Dis. 2016 Aug;20(3):445-56. doi: 10.1016/j.cld.2016.02.004. Epub 2016 Mar 28.

引用本文的文献

1
Phytochemicals Targeting Inflammatory Pathways in Alcohol-Induced Liver Disease: A Mechanistic Review.针对酒精性肝病炎症通路的植物化学物质:一项机制综述
Pharmaceuticals (Basel). 2025 May 11;18(5):710. doi: 10.3390/ph18050710.
2
Outcome of individuals with alcoholic cirrhosis hospitalized with first decompensation and their predictors.首次失代偿住院的酒精性肝硬化患者的结局及其预测因素。
Indian J Med Res. 2024 Feb 1;159(2):213-222. doi: 10.4103/ijmr.ijmr_1690_22. Epub 2024 Apr 4.
3
Synthesis, characterization and hepatoprotective effect of silymarin phytosome nanoparticles on ethanol-induced hepatotoxicity in rats.水飞蓟宾磷脂复合物纳米颗粒的合成、表征及其对大鼠乙醇诱导肝毒性的保肝作用
Bioimpacts. 2023;13(4):301-311. doi: 10.34172/bi.2023.24128. Epub 2023 May 30.
4
Elevated stearoyl-CoA desaturase 1 activity is associated with alcohol-associated liver disease.硬脂酰辅酶 A 去饱和酶 1 活性升高与酒精相关性肝病有关。
Alcohol. 2022 Aug;102:51-57. doi: 10.1016/j.alcohol.2022.04.001. Epub 2022 Apr 19.
5
Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions.2010年至2018年酒精性肝硬化再入院趋势:再入院率及相关医疗负担
World J Hepatol. 2021 Dec 27;13(12):2128-2136. doi: 10.4254/wjh.v13.i12.2128.
6
Proteomics approach to investigate dynamic protein profile involved in high fat diet-induced fatty liver disease in rats.蛋白质组学方法研究高脂饮食诱导的大鼠脂肪肝疾病中涉及的动态蛋白质谱。
J Toxicol Pathol. 2019 Oct;32(4):223-232. doi: 10.1293/tox.2018-0045. Epub 2019 Mar 19.
7
Ginseng Berry Prevents Alcohol-Induced Liver Damage by Improving the Anti-Inflammatory System Damage in Mice and Quality Control of Active Compounds.人参果通过改善小鼠抗炎系统损伤和活性成分质量控制来预防酒精性肝损伤。
Int J Mol Sci. 2019 Jul 18;20(14):3522. doi: 10.3390/ijms20143522.
8
Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids.影响膳食类胡萝卜素吸收、代谢和健康效应的内在和外在因素。
Adv Nutr. 2018 Jul 1;9(4):465-492. doi: 10.1093/advances/nmy025.
9
Effect of Mixed Fruit and Vegetable Juice on Alcohol Hangovers in Healthy Adults.混合果蔬汁对健康成年人酒精性宿醉的影响
Prev Nutr Food Sci. 2018 Mar;23(1):1-7. doi: 10.3746/pnf.2018.23.1.1. Epub 2018 Mar 31.
10
Immunoglobulin A and liver diseases.免疫球蛋白 A 与肝脏疾病。
J Gastroenterol. 2018 Jun;53(6):691-700. doi: 10.1007/s00535-017-1400-8. Epub 2017 Oct 26.

本文引用的文献

1
FOLIC ACID DEFICIENCY AND HEMOCHROMATOSIS.叶酸缺乏与血色素沉着症
Arch Pathol. 1965 Aug;80:153-60.
2
Pharmacological treatment of alcohol dependence: a review of the evidence.酒精依赖的药物治疗:证据综述
JAMA. 1999 Apr 14;281(14):1318-25. doi: 10.1001/jama.281.14.1318.
3
Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease.HFE基因突变的杂合子发生晚期酒精性肝病的风险并未增加。
Gut. 1998 Aug;43(2):262-6. doi: 10.1136/gut.43.2.262.
4
Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress.长期给予乙醇对大鼠肝脏蛋白酶体活性的影响:与氧化应激的关系。
Hepatology. 1999 Jan;29(1):14-20. doi: 10.1002/hep.510290106.
5
Gender differences in alcohol metabolism: relationship to liver volume and effect of adjusting for body mass.酒精代谢中的性别差异:与肝脏体积的关系及体重校正的影响
Gastroenterology. 1998 Dec;115(6):1552-7. doi: 10.1016/s0016-5085(98)70035-6.
6
Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor.乙醇对线粒体谷胱甘肽的选择性消耗使肝细胞对肿瘤坏死因子敏感。
Gastroenterology. 1998 Dec;115(6):1541-51. doi: 10.1016/s0016-5085(98)70034-4.
7
Patterns of alcohol consumption after liver transplantation.肝移植后的饮酒模式。
Gut. 1998 Jul;43(1):140-5. doi: 10.1136/gut.43.1.140.
8
The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype.CYP2E1的RsaI多态性与白种人酒精性肝病易感性:对发病年龄的影响以及对乙醇脱氢酶基因型的依赖性
Pharmacogenetics. 1998 Aug;8(4):335-42. doi: 10.1097/00008571-199808000-00007.
9
Impact of alcohol on the histological and clinical progression of hepatitis C infection.酒精对丙型肝炎感染的组织学及临床进展的影响。
Hepatology. 1998 Sep;28(3):805-9. doi: 10.1002/hep.510280330.
10
Detection of circulating antibodies to malondialdehyde-acetaldehyde adducts in ethanol-fed rats.乙醇喂养大鼠中丙二醛-乙醛加合物循环抗体的检测
Gastroenterology. 1998 Sep;115(3):686-92. doi: 10.1016/s0016-5085(98)70148-9.

酒精性肝病

Alcoholic liver disease.

作者信息

Walsh K, Alexander G

机构信息

Department of Medicine, University of Cambridge, Box 157, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.

出版信息

Postgrad Med J. 2000 May;76(895):280-6. doi: 10.1136/pmj.76.895.280.

DOI:10.1136/pmj.76.895.280
PMID:10775280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1741594/
Abstract

Alcohol is a major cause of liver cirrhosis in the Western world and accounts for the majority of cases of liver cirrhosis seen in district general hospitals in the UK. The three most widely recognised forms of alcoholic liver disease are alcoholic fatty liver (steatosis), acute alcoholic hepatitis, and alcoholic cirrhosis. The exact pathogenesis of alcoholic liver injury is still not clear but immune mediated and free radical hepatic injury are thought to be important. There is increasing interest in genetic factors predisposing to hepatic injury in susceptible individuals. Diagnosis is based on accurate history, raised serum markers such as gamma-glutamyltransferase, mean corpuscular volume, and IgA and liver histology when obtainable. Abstinence is the most important aspect of treatment. Newer drugs such as acamprosate and naltrexone are used to reduce alcohol craving. Vitamin supplements and nutrition are vital while corticosteroids have a role in acute alcoholic hepatitis where there is no evidence of gastrointestinal haemorrhage or sepsis. Liver transplantation has excellent results in abstinent patients with end stage liver disease but there are concerns about recidivism after transplant.

摘要

在西方世界,酒精是肝硬化的主要病因,在英国地区综合医院所见的肝硬化病例中占大多数。三种最广为人知的酒精性肝病形式为酒精性脂肪肝(脂肪变性)、急性酒精性肝炎和酒精性肝硬化。酒精性肝损伤的确切发病机制仍不清楚,但免疫介导和自由基介导的肝损伤被认为很重要。人们越来越关注易患个体中导致肝损伤的遗传因素。诊断基于准确的病史、升高的血清标志物如γ-谷氨酰转移酶、平均红细胞体积和IgA,以及可获得时的肝脏组织学检查。戒酒是治疗最重要的方面。阿坎酸和纳曲酮等新型药物用于减少对酒精的渴望。维生素补充剂和营养至关重要,而皮质类固醇在无胃肠道出血或脓毒症证据的急性酒精性肝炎中发挥作用。肝移植对于终末期肝病的戒酒患者效果极佳,但人们担心移植后会复发。